Literature DB >> 28149010

Association of Interleukin-6 and Myeloperoxidase with Insulin Resistance in Impaired Fasting Glucose Subjects.

Ashish Agarwal1, Anupama Hegde1, Charu Yadav1, Afzal Ahmad1, Poornima Ajay Manjrekar1, Rukmini Mysore Srikantiah1.   

Abstract

Impaired fasting glucose (IFG) is a high risk subclinical condition for the progression of type 2 diabetes mellitus and the hyperglycemia seen in this condition is because of the development of insulin resistance (IR). Obesity, inflammation, oxidative stress and many other factors have been implicated in development of IR in type 2 diabetes mellitus and its successive complications. Current study was aimed to ascertain the correlation of inflammation and oxidative stress markers [interleukin-6 (IL-6) and myeloperoxidase (MPO)] with IR in subjects with IFG. In this study, 80 subjects (40 IFG, 40 healthy controls) aged 25-45 years were selected based on their fasting plasma glucose (FPG) values and clinical history. Serum insulin, IL-6 and MPO were estimated by ELISA method and IR was calculated using Homeostatic Model Assessment Index 2 (HOMA 2) calculator. Pearson's correlation coefficient and independent sample 't' test were used for statistical analysis. IL-6 and MPO were found to be significantly elevated in IFG group and both correlates significantly with IR (r 0.413, r 0.645). Only MPO had significant correlation with FPG (r 0.388). In conclusion, the association of altered levels of IL-6 and MPO with IR are suggestive of a role of inflammation and oxidative stress in the initiation and progression of IR in individuals with IFG.

Entities:  

Keywords:  Impaired fasting glucose; Insulin resistance; Interleukin-6; Myeloperoxidase

Year:  2016        PMID: 28149010      PMCID: PMC5247365          DOI: 10.1007/s12291-016-0567-8

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  27 in total

1.  Amadori adducts activate nuclear factor-kappaB-related proinflammatory genes in cultured human peritoneal mesothelial cells.

Authors:  Julián Nevado; Concepción Peiró; Susana Vallejo; Mariam El-Assar; Nuria Lafuente; Nuria Matesanz; Verónica Azcutia; Elena Cercas; Carlos F Sánchez-Ferrer; Leocadio Rodríguez-Mañas
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

2.  Asymptomatic atherosclerosis and insulin resistance.

Authors:  M Laakso; H Sarlund; R Salonen; M Suhonen; K Pyörälä; J T Salonen; P Karhapää
Journal:  Arterioscler Thromb       Date:  1991 Jul-Aug

Review 3.  Prediabetes and associated disorders.

Authors:  Martin Buysschaert; José Luís Medina; Michael Bergman; Avni Shah; Jaqueline Lonier
Journal:  Endocrine       Date:  2014-10-08       Impact factor: 3.633

4.  Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians.

Authors:  Marina Cardellini; Francesco Andreozzi; Emanuela Laratta; Maria Adelaide Marini; Renato Lauro; Marta Letizia Hribal; Francesco Perticone; Giorgio Sesti
Journal:  Diabetes Metab Res Rev       Date:  2007-02       Impact factor: 4.876

Review 5.  Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection.

Authors:  R Paul Robertson; Jamie Harmon; Phuong Oanh Tran; Yoshito Tanaka; Hiroki Takahashi
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

6.  Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion.

Authors:  B Vozarova; C Weyer; K Hanson; P A Tataranni; C Bogardus; R E Pratley
Journal:  Obes Res       Date:  2001-07

7.  Relationship between serum concentrations of interleukin-6 and tumor necrosis factor alpha in female Turkish subjects with normal and impaired glucose tolerance.

Authors:  D Konukoglu; H Hatemi; H Bayer; N Bağriaçik
Journal:  Horm Metab Res       Date:  2006-01       Impact factor: 2.936

Review 8.  Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

Authors:  Joseph L Evans; Ira D Goldfine; Betty A Maddux; Gerold M Grodsky
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

9.  Association of Insulin Resistance with Serum Interleukin-6 and TNF-α Levels During Normal Pregnancy.

Authors:  Abdolreza Sotoodeh Jahromi; Parvin Zareian; Abdolhossein Madani
Journal:  Biomark Insights       Date:  2011-01-12

10.  Myeloperoxidase: a therapeutic target for preventing insulin resistance and the metabolic sequelae of obesity?

Authors:  Jay W Heinecke; Ira J Goldberg
Journal:  Diabetes       Date:  2014-12       Impact factor: 9.461

View more
  2 in total

1.  Association of Impaired Fasting Glucose and Diabetes with SARS-CoV-2 Spike Antibody Titers after the BNT162b2 Vaccine among Health Care Workers in a Tertiary Hospital in Japan.

Authors:  Zobida Islam; Shohei Yamamoto; Tetsuya Mizoue; Akihito Tanaka; Yusuke Oshiro; Natsumi Inamura; Maki Konishi; Mitsuru Ozeki; Wataru Sugiura; Norio Ohmagari
Journal:  Vaccines (Basel)       Date:  2022-05-13

2.  Jak2 Inhibitor AG490 Improved Poststroke Central and Peripheral Inflammation and Metabolic Abnormalities in a Rat Model of Ischemic Stroke.

Authors:  Ya-Yu Wang; Shih-Yi Lin; Cheng-Yi Chang; Chih-Cheng Wu; Wen-Ying Chen; Su-Lan Liao; Yu-Fan Chen; Wen-Yi Wang; Chun-Jung Chen
Journal:  Antioxidants (Basel)       Date:  2021-12-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.